Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: CYBERKEN who wrote (14056)	2/2/1998 9:02:00 AM
From: Henry Niman	Respond to of 32384

CYBERKEN, Speaking of signposts, the website at home.att.net is being hit at about 200 times per hour!

To: CYBERKEN who wrote (14056)	2/2/1998 10:31:00 AM
From: Henry Niman	Respond to of 32384

CNBC just had Hemant Shaw on again from HKS. He thoiught that just about any combo was possible. He thought that PNU had 6-9 months to fix management problems or they would be fixed from the outside. He thought that most mergers were dependent on mangement wanting to do the deal. He also mentioned increased R&D. As things continue to grow, pharms need to find blockbuster drugs that target markets in excess of $1 Billion. To do so mergers will allow for cuts in management, sales, and marketing (where merged companies would have considerable overlap) and savings would be plowed into R&D to find the blockbuster drugs. At H&Q LGND discussed the upcomimg IND filings slated for this year, and noted that 6 of the 7 addressed Billion dollar markets. LGND's fantastic pipeline will continue to impress the pharmas. The street is usually a bit slower on figuring these things out.